Weight-loss supplements: what is the evidence?
Mark K Huntington1, Roger A Shewmake
1Department of Family Medicine, Sanford School of Medicine, The University of South Dakota, USA.
Summary
Obesity is a major health issue. This article reviews weight-loss supplements, examining their safety, efficacy, and the role of nutrition in weight management strategies.
Area of Science:
- Public Health
- Nutrition Science
- Pharmacology
Background:
- Obesity has reached epidemic levels, necessitating effective public health interventions.
- Numerous weight-loss strategies are employed, including medical, surgical, dietary, and supplement-based approaches.
- Recent regulatory actions by the U.S. Food & Drug Administration (FDA) highlight concerns regarding the safety and efficacy of weight-loss supplements.
Purpose of the Study:
- To critically review the scientific evidence supporting the components of popular weight-loss dietary supplements.
- To discuss the safety and efficacy profiles of various weight-loss supplement ingredients.
- To explore the fundamental role of nutrition in successful and sustainable weight loss.
Main Methods:
- Literature review of scientific studies on weight-loss supplement ingredients.
- Analysis of evidence regarding the efficacy and safety of common dietary supplement components.
- Examination of nutritional principles relevant to weight management.
Main Results:
- Evidence for the efficacy and safety of many weight-loss supplement components is often limited or lacking.
- Some supplements have been subject to regulatory scrutiny due to safety concerns.
- Nutritional strategies remain a cornerstone of effective weight loss.
Conclusions:
- A critical evaluation of weight-loss supplements is warranted due to inconsistent evidence and potential safety issues.
- Consumers should be cautious about the claims made for weight-loss supplements.
- A balanced, evidence-based nutritional approach is essential for achieving and maintaining a healthy weight.
Related Concept Videos
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...